• Go to navigation
  • Go to content
AstraZeneca Clinical Trials

Astrazeneca Worldwide

  • AstraZeneca Websites
AstraZeneca US

Main navigation

  • Home
  • Therapy Areas
    • Oncology/Infection
    • Cardiovascular
    • Gastrointestinal
    • Neuroscience
    • Respiratory/Inflammation
  • Drug Products
    • All Drug Products
  • Diseases & Conditions
    • All Diseases and Conditions
  • Glossary
  • Contact Us
  • Disclosure Commitment

You are here

  • Home
  • Therapy Areas

  • Cardiovascular

The following trials provide information to treat various types of cardiovascular diseases, both for ongoing and completed clinical trials.  For more information on this therapy area please click here.

There are a number of ways to help you find trial information.  By using these filters you can find (i) recruiting status, (ii) therapy area, (iii) product and/or (iv) phase of drug development.  You can use one or all filters to identify your specific needs.

When a trial completes the results are reported here no later than one year after completion – this is why you may sometimes find that a Report is unavailable when you are searching through ‘closed’ trials.

  • Expand All
  • Collapse All
  • Pages
  • Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • Next
  • expand A descriptive study of the efficacy and safety of ONGLYZA (Saxagliptin) under conditions of actual use in the Philippines
    Study Id
    NIS-CPH-DUM-2010/1
    Disease
    diabetes type 2
    Drug Name
    Onglyza
    Study Name
    NIS-CPH-DUM-2010/1
    Recruiting Status
    Not Yet Recruiting
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand LIPID-LOWERING THERAPY FOR SECONDARY PREVENTION IN PATIENTS UNDERGOING ELECTIVE PERCUTANEOUS CORONARY INTERVENTION (PCI) A 10-week, open-label, non-interventional study of total cholesterol/LDL-cholesterol management in real life in coronary patients hospitalised for elective PCI
    Study Id
    NIS-CSI-DUM-2010/1
    Disease
    coronary artery disease
    Drug Name
    non drug study (cardiovascular)
    Study Name
    NIS-CSI-DUM-2010/1
    Recruiting Status
    Not Yet Recruiting
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand Repeated dosing to SS
    Study Id
    SH-SBC-0010
    Disease
    diabetes mellitus
    Drug Name
    Galida
    Study Name
    SH-SBC-0010
    Recruiting Status
    Closed
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand Safety &amp tolerability 3 mg
    Study Id
    SH-SBC-0009
    Disease
    diabetes mellitus
    Drug Name
    Galida
    Study Name
    SH-SBC-0009
    Recruiting Status
    Closed
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand IRS-CD2-Japan1
    Study Id
    SH-SBC-0008
    Disease
    diabetes mellitus
    Drug Name
    Galida
    Study Name
    SH-SBC-0008
    Recruiting Status
    Closed
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand IRS-CD2-Interaction 1
    Study Id
    SH-SBC-0006
    Disease
    diabetes mellitus
    Drug Name
    Galida
    Study Name
    SH-SBC-0006
    Recruiting Status
    Closed
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand IRS-CD2- Concept
    Study Id
    SH-SBC-0005
    Disease
    diabetes mellitus
    Drug Name
    Galida
    Study Name
    SH-SBC-0005
    Recruiting Status
    Closed
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand IRS-CD2-BA1
    Study Id
    SH-SBC-0004
    Disease
    diabetes mellitus
    Drug Name
    Galida
    Study Name
    SH-SBC-0004
    Recruiting Status
    Closed
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand IRS-CD2-Single vs repeated
    Study Id
    SH-SBC-0003
    Disease
    diabetes mellitus
    Drug Name
    Galida
    Study Name
    SH-SBC-0003
    Recruiting Status
    Closed
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand IRS-CD2-ADME
    Study Id
    SH-SBC-0002
    Disease
    diabetes mellitus
    Drug Name
    Galida
    Study Name
    SH-SBC-0002
    Recruiting Status
    Closed
    Protocol Status
    Not Available
    Report Status
    Not Available
  • Pages
  • Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • Next
  • Expand All
  • Collapse All

Page tools

  • Print
  • Bookmark this page

Legal notices

  • Legal notice
  • Privacy policy
  • © AstraZeneca 2013